FBT
EW icon

First Bank & Trust’s Edwards Lifesciences EW Stock Holding History

First Bank & Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$695K Hold
7,680
– – 0.1% 145
2026
Q1 		$615K Buy
7,680
+1,865
+32% +$154K 0.1% 136
2025
Q4 		$496K Sell
5,815
-280
-5% -$23K 0.08% 160
2025
Q3 		$474K Sell
6,095
-320
-5% -$25K 0.08% 154
2025
Q2 		$502K Buy
6,415
+82
+1% +$6.12K 0.09% 140
2025
Q1 		$459K Buy
6,333
+219
+4% +$15.7K 0.09% 143
2024
Q4 		$453K Sell
6,114
-5,977
-49% -$418K 0.09% 145
2024
Q3 		$798K Sell
12,091
-9,845
-45% -$715K 0.15% 100
2024
Q2 		$2.03M Buy
21,936
+956
+5% +$84.7K 0.41% 56
2024
Q1 		$2M Buy
20,980
+490
+2% +$41.2K 0.41% 57
2023
Q4 		$1.56M Sell
20,490
-3,108
-13% -$216K 0.38% 68
2023
Q3 		$1.63M Sell
23,598
-55
-0.2% -$4.42K 0.43% 58
2023
Q2 		$2.23M Buy
23,653
+1,288
+6% +$112K 0.57% 43
2023
Q1 		$1.85M Buy
22,365
+3,750
+20% +$295K 0.49% 45
2022
Q4 		$1.39M Sell
18,615
-3,481
-16% -$268K 0.39% 63
2022
Q3 		$1.83M Buy
22,096
+2,200
+11% +$212K 0.67% 37
2022
Q2 		$1.89M Buy
19,896
+3,711
+23% +$384K 0.62% 39
2022
Q1 		$1.91M Buy
16,185
+1,820
+13% +$204K 0.59% 40
2021
Q4 		$1.86M Buy
14,365
+280
+2% +$32.7K 0.78% 33
2021
Q3 		$1.59M Buy
14,085
+24
+0.2% +$2.74K 0.73% 37
2021
Q2 		$1.46M Sell
14,061
-259
-2% -$24.4K 0.7% 41
2021
Q1 		$1.2M Buy
14,320
+4,251
+42% +$359K 0.6% 47
2020
Q4 		$919K Sell
10,069
-5,205
-34% -$432K 0.58% 51
2020
Q3 		$1.22M Sell
15,274
-6,293
-29% -$491K 0.81% 39
2020
Q2 		$1.49M Buy
21,567
+8,133
+61% +$578K 1.12% 29
2020
Q1 		$845K Buy
13,434
+834
+7% +$60.1K 0.76% 39
2019
Q4 		$980K Sell
12,600
-1,200
-9% -$93.7K 0.71% 43
2019
Q3 		$1.01M Buy
13,800
+456
+3% +$32K 0.76% 41
2019
Q2 		$822K Buy
13,344
+204
+2% +$12.3K 0.66% 49
2019
Q1 		$838K Sell
13,140
-2,190
-14% -$125K 0.65% 54
2018
Q4 		$783K Buy
15,330
+474
+3% +$24K 0.66% 50
2018
Q3 		$714K Hold
14,856
– – 0.54% 66
2018
Q2 		$721K Buy
14,856
+1,659
+13% +$77.4K 0.55% 62
2018
Q1 		$614K Sell
13,197
-30
-0.2% -$1.3K 0.49% 64
2017
Q4 		$497K Sell
13,227
-231
-2% -$8.48K 0.39% 74
2017
Q3 		$490K Buy
13,458
+141
+1% +$5.38K 0.4% 71
2017
Q2 		$525K Buy
13,317
+228
+2% +$8.32K 0.44% 68
2017
Q1 		$410K Buy
13,089
+10,599
+426% +$332K 0.35% 76
2016
Q4 		$78K Buy
+2,490
New +$80.7K 0.07% 182

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $1.85B AUM 62.46% 1-Year Est. Return

First Bank & Trust's EW Position: Q2 2026 in Review

First Bank & Trust held its Edwards Lifesciences (EW) position steady in Q2 2026 at 7,680 shares worth $695K. The position accounts for 0.1% of the portfolio, ranked #145.

First Bank & Trust first reported a position in EW in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.23M in Q2 2023. 232 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • First Bank & Trust held 7,680 shares of Edwards Lifesciences worth $695K as of Q2 2026.
  • First Bank & Trust left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.1% of First Bank & Trust's portfolio in Q2 2026, its #145 holding.
  • First Bank & Trust first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 39 quarters since.
  • First Bank & Trust's Edwards Lifesciences position peaked at $2.23M in Q2 2023.
  • 232 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on First Bank & Trust's 13F filing for Q2 2026, filed 9 Jul 2026.